Epizyme Inc. diskutieren
Epizyme Inc.
WKN: A1T9L2 / Symbol: EPZM / Name: Epizyme / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
1,43 €
-
(Zielkurs erreicht)
Gesundheit | Biotechnologie | Vereinigte Staaten
$$
(Vom Mitglied beendet)
$ EPZM PT raiste auf $ 27 von $ 21 bei Suntrust
a +
(Laufzeit überschritten)
stratec stimmt dem Sentiment von 'Buy' zu
Oppenheimer's call:An annoncement of the partial clinical hold being lifted by FDA supports our outlook for tazemetostat. Tazemetostat is currently being studied in clinical programs in INI-1 negative tumors, synovial sarcomas, follicular lymphoma, diffuse large B-cell lymphoma (DLBCL), and mesothelioma. While the partial clinical hold may have delayed enrollment in some studies, these are not currently factored into our outlook; therefore, the hold had little impact on our outlook. The news removes a regulatory overhang and supports our outlook for Epizyme.”
Buy Epizyme Inc.
Buy Epizyme Inc.
Sell mit Kursziel 14,0
Buy mit Kursziel 20,0
Buy mit Kursziel 24,8
The FDA's Oncologic Drugs Advisory Committee will meet on Wednesday, December 18, to review and discuss Epizyme's marketing application for tazemetostat for the treatment of patients with metastatic or locally advanced epithelioid sarcoma not eligible for curative surgery.
Kursziel geändert auf 26,0
Sell Epizyme Inc.
Sell Epizyme Inc.
Sell Epizyme Inc.
Neueste Beiträge
Vassago1 in Restorbio Inc. diskutieren, Adicet Bio Inc.